A minimally invasive alternative to open brain surgery.
You just clicked a link to go to another website. If you continue, you will leave this site and go to a site run by someone else.
Medtronic does not review or control the content on the other website, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in the United Kingdom.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
A minimally invasive alternative to open brain surgery.
Brain cancer is a rare and deadly malignancy with a low survival rate. The prospect of having a surgical procedure performed on the brain can be frightening for you as a patient.
The experts at your hospital can help put your mind at ease with today’s most cutting edge, minimally invasive MRI-guided laser ablation technology. A less invasive procedure can result in more comfort for you.
Visualase™ is an MRI-guided laser ablation system used to perform a minimally invasive surgical procedure called laser interstitial thermal therapy (LITT).
LITT offers an alternative to open brain surgery.
Compared to open brain surgery, Visualase™ MRI-guided laser ablation offers patients a significantly shorter hospital stay with the patient staying 1 day vs 5 days1-8
Minimal hair shaving
A small, no scarring (4mm) incision
Decreased risk of infection9,10
Higher patient satisfaction1,11,12
These images are sent to the LITT workstation, which creates “maps” targeting the spots where the ablation will be applied. Precise measurement and skilled guidance help protect healthy tissue from damage.
The Visualase™ system delivers laser energy through a small catheter into the problematic lesion in the brain. The surgeon directs a laser probe toward the area in the brain where the problem lesion is located. The probe placement is confirmed by the MRI images. Laser energy is delivered to the tip of the probe to destroy the abnormal tissue.
Once the area has been ablated, the neurosurgeon removes the probe and the incision is closed with one or two sutures (stitches).
Approved in Europe
The Visualase™ MRI-Guided Laser Ablation System is indicated for use as a minimally invasive procedure to ablate, necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy under magnetic resonance imaging (MRI) guidance for wavelengths 800nm through 1064nm in cranial neurosurgery.
Over 10,000 procedures
Over 10,000 neurosurgical procedures have been performed in over 210 centers worldwide.
Positive outcomes
71% of patients experienced symptom resolution/reduction (brain metastasis)13
Disclaimer: Information contained herein is not medical advice and should not be used as an alternative to speaking with your doctor. Discuss indications, contraindications, warnings, precautions, adverse events and any further information with your health care professional. Please note that the intended use of a product may vary depending on geographical approvals. Medtronic products placed on European markets bear the CE mark and the UKCA mark (if applicable).
Kang JY, Wu C, Tracy J, et al. Laser interstitial thermal therapy for medically intractable mesial temporal lobe epilepsy. Epilepsia. 2016;57(2):325-334. doi:10.1111/epi.13284
Waseem H, Osborn KE, Schoenberg MR, et al. Laser ablation therapy: An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50. Epilepsy Behav. 2015;51:152-157. doi:10.1016/j.yebeh.2015.07.022
Jethwa PR, Barrese JC, Gowda A, Shetty A, Danish SF. Magnetic resonance thermometry-guided laser-induced thermal therapy for intracranial neoplasms: initial experience. Neurosurgery. 2012;71(1 Suppl Operative):133-145. doi:10.1227/NEU.0b013e31826101d4
Lewis EC, Weil AG, Duchowny M, Bhatia S, Ragheb J, Miller I. MR-guided laser interstitial thermal therapy for pediatric drug-resistant lesional epilepsy. Epilepsia. 2015;56(10):1590-1598. doi:10.1111/epi.13106
Patel P, Patel NV, Danish SF. Intracranial MR-guided laser-induced thermal therapy: single-center experience with the Visualase thermal therapy system. J Neurosurg. 2016;125(4):853-860. doi:10.3171/2015.7.JNS15244
Wilfong AA, Curry DJ. Hypothalamic hamartomas: optimal approach to clinical evaluation and diagnosis. Epilepsia. 2013;54 Suppl 9:109-114. doi:10.1111/epi.12454
Willie JT, Laxpati NG, Drane DL, et al. Real-time magnetic resonance-guided stereotactic laser amygdalohippocampotomy for mesial temporal lobe epilepsy. Neurosurgery. 2014;74(6):569-585. doi:10.1227/NEU.0000000000000343
Petito GT, Wharen RE, Feyissa AM, Grewal SS, Lucas JA, Tatum WO. The impact of stereotactic laser ablation at a typical epilepsy center. Epilepsy Behav. 2018;78:37-44. doi:10.1016/j.yebeh.2017.10.041
Fabiano AJ, Alberico RA. Laser-interstitial thermal therapy for refractory cerebral edema from post-radiosurgery metastasis. World Neurosurg. 2014;81(3-4):652.e1-652.e6524. doi:10.1016/j.wneu.2013.10.034
Carpentier A, McNichols RJ, Stafford RJ, et al. Laser thermal therapy: real-time MRI-guided and computer-controlled procedures for metastatic brain tumors. Lasers Surg Med. 2011;43(10):943-950. doi:10.1002/lsm.21138
Khu KJ, Doglietto F, Radovanovic I, et al. Patients’ perceptions of awake and outpatient craniotomy for brain tumor: a qualitative study. J Neurosurg. 2010;112(5):1056-1060. doi:10.3171/2009.6.JNS09716
Kim AH, Tatter S, Rao G, et al. Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System (LAANTERN): 12-Month Outcomes and Quality of Life After Brain Tumor Ablation. Neurosurgery. 2020;87(3):E338-E346. doi:10.1093/neuros/nyaa071
Rao MS, Hargreaves EL, Khan AJ, et al. Magnetic resonance-guided laser ablation improves local control for postradiosurgery recurrence and/or radiation necrosis. Neurosurgery 2014;74:658-667.